Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-23T07:01:42.395Z Has data issue: false hasContentIssue false

Paula T. Hammond selected for 2019 David Turnbull Lectureship Award

Published online by Cambridge University Press:  06 November 2019

Abstract

Type
Society News
Copyright
Copyright © Materials Research Society 2019 

The Materials Research Society’s (MRS) David Turnbull Lectureship Award recognizes the career of a scientist who has made outstanding contributions to understanding materials phenomena and properties through research, writing, and lecturing, as exemplified by the late David Turnbull of Harvard University. Paula T. Hammond, Massachusetts Institute of Technology (MIT), has been selected to give the Turnbull Lecture at the 2019 MRS Fall Meeting in Boston. She is cited “for her contributions to the science, engineering and applications of self-assembled macromolecular systems.”

Hammond is the David H. Koch Chair Professor of Engineering at MIT and Head of the Department of Chemical Engineering. She is a member of MIT’s Koch Institute for Integrative Cancer Research, the MIT Energy Initiative, and a founding member of the MIT Institute for Soldier Nanotechnologies. Her research in nanomedicine encompasses the development of biomaterials to enable drug delivery from surfaces with spatiotemporal control. She investigates novel responsive polymer architectures for targeted nanoparticle drug and gene delivery, and has developed self-assembled materials systems for electrochemical energy devices.

Hammond was elected into the National Academy of Sciences in 2019, the National Academy of Engineering in 2017, the National Academy of Medicine in 2016, and into the 2013 Class of the American Academy of Arts & Sciences. She won the American Chemical Society Award in Applied Polymer Science in 2018, the 2013 AIChE Charles M. A. Stine Award, and the 2014 AIChE Alpha Chi Sigma Award for Chemical Engineering Research. She received her bachelor’s and PhD degrees in chemical engineering from MIT.

Hammond has designed multilayered nanoparticles to deliver a synergistic combination of siRNA or inhibitors with chemotherapy drugs in a staged manner to tumors, leading to significant decreases in tumor growth and a great lowering of toxicity. She has published more than 320 papers and has filed more than 20 patent applications. She is the co-founder and member of the Scientific Advisory Board of LayerBio, Inc. and is a member of the Scientific Advisory Board of Moderna, Inc.